Cargando…
High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol
BACKGROUND: Detection of cell-free methylated DNA in plasma is a promising tool for tumour diagnosis and monitoring. Due to the very low amounts of cell-free DNA in plasma, analytical sensitivity is of utmost importance. The vast majority of currently available methods for analysing DNA methylation...
Autores principales: | Pedersen, Inge Søkilde, Krarup, Henrik Bygum, Thorlacius-Ussing, Ole, Madsen, Poul Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324385/ https://www.ncbi.nlm.nih.gov/pubmed/22448717 http://dx.doi.org/10.1186/1471-2199-13-12 |
Ejemplares similares
-
The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2018) -
Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma
por: Henriksen, Stine Dam, et al.
Publicado: (2017) -
Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2017) -
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
por: Stubbe, Benjamin Emil, et al.
Publicado: (2021) -
Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
por: Henriksen, Stine Dam, et al.
Publicado: (2016)